在生物制药过程中用于差异估计的贝叶斯分层建模
Sonja Schach1, Tobias Eilert2, Beate Presser1
1CMC Statistics Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Straße 65, 88397 Biberach an der Riß, Germany.
一个新的贝叶斯模型使用元分析增强生物制药过程方差估计. 这种方法在有限的数据中提高了关键质量属性的可靠性,有助于更快的药物开发和确保患者安全.
科学领域:
- 生物制药制造业 生物制药制造业
- 统计建模 统计建模
- 通过设计的质量.
背景情况:
- 准确的过程方差估计在生物制药制造中至关重要.
- 有限的数据可用性对可靠的差异确定构成重大挑战.
- 现有的方法与数据稀缺性作斗争,影响过程开发和质量评估.
研究的目的:
- 介绍一个贝叶斯层次模型,用于对过程方差的元分析.
- 在数据稀缺的场景中,改进对流程差异和关键质量属性 (CQA) 的估计.
- 加强过程模型的评估,支持生物制药开发的质量.
主要方法:
- 开发一个贝叶斯的层次模型用于元分析.
- 整合来自多个产品的数据,以增强差异估计.
- 该模型应用于上游和下游的制造工艺.
主要成果:
- 该模型提供了更可靠的过程方差估计,特别是在有限的数据.
- 通过模拟研究证明了有效性.
- 对未来的CMC (化学,制造和控制) 药物开发利用历史数据的潜力.
结论:
- 拟议的统计模型有效地解决了生物制药过程方差分析中的数据稀缺问题.
- 它有助于更强大的流程评估和质量保证.
- 该方法可以加快新疗法进入市场的速度,同时保持患者安全和产品质量.
更多相关视频
09:28Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation
Published on: May 18, 2020
09:12Optimization of Processing of Tiebangchui with Highland Barley Wine Based on the Box-Behnken Design Combined with the Entropy Method
Published on: May 19, 2023
相关概念视频
Mechanistic Models: Compartment Models in Individual and Population Analysis
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Analysis of Population Pharmacokinetic Data
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Mechanistic Models: Overview of Compartment Models
